PRVB

Provention Bio, Inc. Common Stock
PRVB

Overview Fund Activity
Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

63 hedge funds and large institutions have $96.2M invested in Provention Bio, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 16 closing their positions.

Holders
63
Holders Change
+3
Holders Change %
+5%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
22
Increased
20
Reduced
17
Closed
16
Calls
$1.83M
Puts
$1.38M
Net Calls
+$453K
Net Calls Change
-$1.5M

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$5.34M
2
Invesco
2
Invesco
Georgia
$4.67M
3
OM
3
Opaleye Management
Massachusetts
$1.53M
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$3.3M
5
EGI
5
EAM Global Investors
California
$1.31M

Top Sellers

1
Qube Research & Technologies (QRT)
1
Qube Research & Technologies (QRT)
United Kingdom
$331K
2
LCM
2
Laurion Capital Management
New York
$0
3
ECM
3
ExodusPoint Capital Management
New York
$160K
4
CS
4
Credit Suisse
Switzerland
$200K
5
Stifel Financial
5
Stifel Financial
Missouri
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ARMC
76
American Research & Management Company
Massachusetts
– -$6K -400 Closed
RCA
77
Ranch Capital Advisors
Florida
– -$6K -395 Closed
Federated Hermes
78
Federated Hermes
Pennsylvania
– -$2K -105 Closed
1 2 3
4